# cbdMD (YCBD) — Earnings

YCBD · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/ycbd/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.11 |
| EPS estimate | −$0.03 |
| EPS surprise | −266.67% |
| Revenue surprise | −2.44% |
| Revenue | $5.5M |
| Revenue estimate | $5.7M |
| Reported | Aug 13, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1644903/000143774926027665/ycbd20260630_10q.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/dd320149-5664-755f-54a3-e9be5804926a.html) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2026 | Aug 13, 2026 | −$0.03 | −$0.11 | -266.67% | $5.7M | $5.5M |
| Q2 2026 | May 14, 2026 | −$0.05 | −$0.08 | -60.00% | $5.3M | $5.6M |
| Q1 2026 | Feb 17, 2026 | −$0.06 | −$0.04 | 33.33% | $4.9M | $5.0M |
| Q4 2025 | Dec 19, 2025 | −$0.07 | $2.78 | 4071.43% | $4.7M | $4.7M |
| Q3 2025 | Aug 14, 2025 | −$0.02 | −$0.21 | -950.00% | $5.3M | $4.6M |
| Q2 2025 | May 15, 2025 | −$1.60 | −$1.90 | -18.75% | $5.1M | $4.7M |
| Q1 2025 | Feb 13, 2025 | −$2.96 | −$1.76 | 40.54% | $5.2M | $5.1M |
| Q4 2024 | Dec 18, 2024 | −$3.60 | $0.00 | 100.00% | $4.8M | $4.6M |
| Q3 2024 | Aug 14, 2024 | −$4.96 | −$1.20 | 75.81% | $4.9M | $5.2M |
| Q2 2024 | May 15, 2024 | −$6.00 | −$10.80 | -80.00% | $5.4M | $4.4M |
| Q1 2024 | Feb 13, 2024 | −$5.92 | −$5.36 | 9.46% | $5.8M | $5.4M |
| Q4 2023 | Dec 22, 2023 | −$6.08 | −$46.96 | -672.37% | $6.1M | $5.7M |
| Q3 2023 | Aug 10, 2023 | −$21.60 | −$9.28 | 57.04% | $13.4M | $6.1M |
| Q2 2023 | May 15, 2023 | −$28.80 | −$13.92 | 51.67% | $12.0M | $6.2M |
| Q1 2023 | Feb 13, 2023 | −$126.00 | −$28.80 | 77.14% | $11.5M | $6.1M |
| Q1 2022 | Feb 10, 2022 | −$9.00 | −$126.00 | -1300.00% | $13.3M | $9.3M |
| Q4 2021 | Dec 17, 2021 | −$16.20 | −$25.20 | -55.56% | $11.3M | $9.8M |
| Q3 2021 | Aug 12, 2021 | −$14.40 | $7.20 | 150.00% | $12.6M | $10.6M |
| Q2 2021 | May 12, 2021 | −$10.80 | −$86.40 | -700.00% | $12.6M | $11.8M |
| Q1 2021 | Feb 9, 2021 | −$7.20 | −$64.80 | -800.00% | $12.2M | $12.3M |

## Frequently Asked Questions

### When did cbdMD (YCBD) last report earnings?

cbdMD last reported on Aug 13, 2026, covering fiscal Q3 2026.

### Did YCBD beat earnings estimates?

No. cbdMD reported EPS of −$0.11 for Q3 2026 against a −$0.03 estimate — a 266.67% miss.

### How much revenue did YCBD report last quarter?

cbdMD reported $5.5M in revenue for Q3 2026, against a consensus estimate of $5.7M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).